These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7527679

  • 1. Analysis of bone marrow stem cell.
    Terstappen LW, Huang S.
    Blood Cells; 1994; 20(1):45-61; discussion 61-3. PubMed ID: 7527679
    [Abstract] [Full Text] [Related]

  • 2. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S, Law P, Young D, Ho AD.
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [Abstract] [Full Text] [Related]

  • 3. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
    de Wynter EA, Nadali G, Coutinho LH, Testa NG.
    Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
    [Abstract] [Full Text] [Related]

  • 4. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells.
    Huang S, Terstappen LW.
    Blood; 1994 Mar 15; 83(6):1515-26. PubMed ID: 7510144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF.
    Exp Hematol; 1994 Dec 15; 22(13):1264-72. PubMed ID: 7525328
    [Abstract] [Full Text] [Related]

  • 11. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S, Chen Z, Yu JF, Young D, Bashey A, Ho AD, Law P.
    Stem Cells; 1999 Dec 15; 17(5):265-72. PubMed ID: 10527461
    [Abstract] [Full Text] [Related]

  • 12. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Hoffman R, Law P, Srour EF.
    Blood Cells; 1994 Dec 15; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [Abstract] [Full Text] [Related]

  • 13. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF, Van Bockstaele DR, Plum J, Moulijn A, Rodrigus I, Lardon F, De Smedt M, Nijs G, Lenjou M, Loquet P, Berneman ZN, Snoeck HW.
    Exp Hematol; 1998 Oct 15; 26(11):1034-42. PubMed ID: 9766443
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N, Ishikawa R, Inoue H, Nishikawa M, Kakeda M, Yoneya T, Tsumura H, Ohashi H, Yamaguchi Y, Motoki K, Sudo T, Mori KJ.
    Exp Hematol; 1996 Sep 15; 24(11):1312-21. PubMed ID: 8862442
    [Abstract] [Full Text] [Related]

  • 15. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Sep 15; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 16. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
    Cardoso AA, Watt SM, Batard P, Li ML, Hatzfeld A, Genevier H, Hatzfeld J.
    Exp Hematol; 1995 May 15; 23(5):407-12. PubMed ID: 7536682
    [Abstract] [Full Text] [Related]

  • 17. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H, Huang S, Gong F, Tian L, Chen Z.
    Cancer Genet Cytogenet; 2005 Feb 15; 157(1):33-6. PubMed ID: 15676144
    [Abstract] [Full Text] [Related]

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L, Zeng L, Hiti AL, Weinberg KI, Malik P.
    Exp Hematol; 2004 May 15; 32(5):483-93. PubMed ID: 15145217
    [Abstract] [Full Text] [Related]

  • 19. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
    Waller EK, Huang S, Terstappen L.
    Blood; 1995 Jul 15; 86(2):710-8. PubMed ID: 7541673
    [Abstract] [Full Text] [Related]

  • 20. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM, Shields LE, Andrews RG.
    Stem Cells; 1998 Jul 15; 16(5):343-8. PubMed ID: 9766814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.